Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity

Journal of Pathology

Volumn 181, Issue 2, 1997, Pages 172-177

  Eerola, Anna Kaisa ^b   Törmänen, Ulla ^b   Rainio, Pekka ^b   Sormunen, Raija ^b   Bloigu, Risto ^b   Vähäkangas, Kirsi ^b   Lehto, Veli Pekka ^b   Soini, Ylermi ^b   Pääkkö, Paavo ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NONE

Author keywords

(SCLC); Apoptosis; bcl 2; Cell proliferation; p53; Small cell lung carcinoma

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MORPHOMETRICS; PRIORITY JOURNAL; SMOKING; TUMOR NECROSIS;

APOPTOSIS; CARCINOMA, SMALL CELL; CELL DIVISION; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; NECROSIS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1842406622     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199702)181:2<172::AID-PATH715>3.0.CO;2-2     Document Type: Article

References (34)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in-tissue kinetics. Br J Cancer 1972; 26: 239-257.
2. Wyllie AH. Apoptosis. Br J Cancer 1993; 67: 205-208.
3. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1993; 73: 2013-2026.
4. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
5. Korkolopoulou P, Oates J, Crocker J, Edwards J. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen. J Clin Pathol 1993; 46: 1093-1096.
6. Kawai T, Suzuki M, Kono S, et al. Proliferating cell nuclear antigen Ki-67 in lung carcinoma. Cancer 1994; 74: 2468-2475.
7. Kerr JFR, Searle JA. Suggested explanation for the paradoxically slow growth rate of basal-cell carcinomas that contain numerous mitotic figures. J Pathol 1972; 107: 41-44.
8. Hockenbery D, Nuñez G, Milliman C, Schreider RD, Korsmeyer S. bcl-2 in an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
9. Vaux DL. Toward an understanding of the molecular mechanism of physiological cell death. Proc Natl Acad Sci USA 1993; 90: 786-789.
10. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in human colon tumour derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495-4499.
11. Yonish-Rouach E, Grunwald D, Wilder S, et al. p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol 1993; 13: 1415-1423.
12. Lowe SW, Bodis S, McClatchey A, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-810.
13. Bardeesy N, Beckwith JB, Pelletier J. Clonal expansion and attenuated apoptosis in Wilm's tumours are associated with p53 gene mutations. Cancer Res 1995; 55: 215-219.
14. World Health Organization. Histological Typing of Lung Tumours. International Classification of Tumors. No. 1. 2nd edn. Geneva: World Health Organization. 1981.
15. Pääkkö P, Sormunen R, Risteli L, Risteli J, Ala-Kokko L, Ryhänen L. Malotilate prevents accumulation of type III pN-collagen, type IV collagen, and laminin in carbon tetrachloride-induced pulmonary fibrosis in rats. Am Rev Respir Dis 1989; 139: 1105-1111.
16. Törmänen U, Eerola A-K, Rainio P, et al. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 1995; 55: 5595-5602.
17. Soini Y, Kamel D, Pääkkö P, Lehto V-P, Oikarinen A, Vähäkangas K. Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions. Br J Dermatol 1994; 131: 514-520.
18. Soini Y, Kamel D, Nuorva K, Lane DP, Vähäkangas K, Pääkkö P. Low p53 protein expression in salivary gland tumours compared with lung carcinomas. Virchows Arch A 1992; 421: 415-420.
19. Aihara M, Truong LD, Dunn JK, Wheeler T, Scardino PT, Thompson TC. Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol 1994; 25: 797-801.
20. Yoshino T, Kondo E, Cao L, et al. Inverse expression of bcl-2 and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 1994; 7: 1856-1861.
21. Lipponen PK, Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 1994; 173: 333-339.
22. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
23. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
24. Bringham BA, Bunn PA, Minna JD, Cohen MH, Ihde DC, Shackney SE. Growth rates of small cell bronchogenic carcinomas. Cancer 1978; 42: 2880-2886.
25. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Mol Cell Biol 1988; 8: 531-539.
26. D'Amico D, Carbone D, Mitsudomi T, et al. High frequency of somatically acquired p53 mutations in small cell lung cancer cell lines and tumors. Oncogene 1992; 7: 339-346.
27. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-299.
28. Allsopp TE, Wyatt S, Person HF, Davies AM. The proto-oncogene bcl-2 can selectively rescue neurotropic factor-dependent neurons from apoptosis. Cell 1993; 73: 295-307.
29. Lagasse E, Weissman IL. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 1994; 179: 1047-1052.
30. Reed JC. bcl-2 and the regulation of programmed cell death (Mini-review.). J Cell Biol 1994; 124: 1-6.
31. L and bcl-2. displaces bax and promotes cell death. Cell 1995; 80: 285-291.
32. Yin X-M, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 1994; 369: 321-323.
33. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y. Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 1994; 54: 6-8.
34. Arends MJ, McGregor AH, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras and HPV oncogenes. Am J Pathol 1994; 144: 1045-1057.